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Abstract 
High levels of total- and LDL-cholesterol in blood are risk factors related to cardio-
vascular disease. One of several measures to prevent this is consumption of the 
viscous soluble fibre β-glucan that in high amount is found in oats. In 2006, EFSA 
approved the health claim that a dose of at least 3 g β-glucan per day maintains 
normal blood cholesterol concentrations. The cholesterol-lowering properties of β-
glucan have been shown to vary based on the processing and use in products. The 
aim of this literature review was to compare the cholesterol-lowering effect of oat 
β-glucan in ready-to-eat cereals and bread. These two products are easily accessible 
and common in the western diet. They can contain β-glucan of the same source but 
differ in several steps of manufacturing.  
The cholesterol lowering property of oat β-glucan is primarily affected by the 
solubility and molecular weight distribution. In bread making, fermentation and the 
use of flour with low falling number can decrease molecular weight and increase 
solubility. In the manufacturing extruded ready-to-eat cereals, high molecular 
weight is retained and solubility increased. One of the possible cholesterol lowering 
mechanisms of β-glucan is by increased hepatic bile acid production from choles-
terol either endogenously synthesized or taken from the circulation.  
Six studies with ready-to-eat cereals and five studies with bread or muffins, cook-
ies and buns were included for comparison. Eight out of the selected eleven studies 
reported a significant decrease in total- and LDL-cholesterol. Regarding dose of β-
glucan and study subjects, the studies with cereals had more similarities and 
achieved more consistent results compared to the studies with bread. Ready-to-eat 
cereals seem to be a more favourable product than bread for oat β-glucan consump-
tion in order to achieve a cholesterol reduction, due to more beneficial effects of 
processing on molecular weight and solubility of the β-glucan. 
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Sammanfattning 
Höga nivåer av total- och LDL-kolesterol i blod utgör en riskfaktor för hjärt-
kärlsjukdom. En av flera möjliga åtgärder för att förhindra insjuknande är konsumt-
ion av den viskösa och lösliga fibern β-glukan, som i stora mängder finns i havre. 
EFSA godkände 2006 hälsopåståendet att en dos av minst 3 g β-glukan per dag 
upprätthåller normala blodkolesterolkoncentrationer. Bearbetning och användning i 
produkter har visat sig påverka graden av β-glukanets kolesterolsänkande effekt. 
Syftet men denna litteraturstudie var att jämföra kolesterolsänkning efter konsumt-
ion av β-glukan i flingor respektive bröd. Dessa två livsmedel är lättillgängliga och 
vanliga i den västerländska kosten samt kan innehålla samma källa till β-glukan, 
men skiljer sig på flera punkter i tillverkningsprocessen.  
β-Glukanets kolesterolsänkande egenskaper påverkas primärt av löslighet och 
molekylviktsfördelning. Vid brödbakning kan jäsning och användning av mjöl med 
lågt falltal minska molekylvikten och öka lösligheten. Vid tillverkning av extrude-
rade flingor bibehålls hög molekylvikt och lösligheten ökar. En av de möjliga mek-
anismer genom vilken β-glukan sänker kolesterolnivåer är ökad gallsyraproduktion 
i levern där kolesterol som antingen syntetiseras endogent eller tas från cirkulation-
en används.  
Sex studier med flingor och fem studier med bröd eller muffins, kakor och bullar 
jämfördes. Åtta av de elva utvalda studierna rapporterade en signifkant minskning 
av total- eller LDL-kolesterol. Studierna på flingor hade i jämförelse med studierna 
på bröd mer likheter gällande dos av β-glukan och försökspersoner. Analysen av 
studierna tyder på att flingor med β-glukan ger en större kolesterolminskning än 
bröd på grund av fördelaktigare processeffekter på molekylvikt och lösligheten hos 
β-glukanet.   
Nyckelord: havre, β-glucan, total-kolesterol, LDL-kolesterol, flingor, bröd  
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1 Introduction 
Increased total- and LDL-cholesterol concentrations in blood are risk factors relat-
ed to cardiovascular disease, which is one of today’s most common cause of mor-
tality in Sweden (Risérus et al., 2013). Therefore, a lifestyle that prevents high 
cholesterol-levels is promoted. A healthy diet is important and this includes a rec-
ommended intake of of 25-35 g dietary fibre each day (NNR, 2012). 
Lowered cholesterol in response to consumption of rolled oats was observed al-
ready in 1963 (De Groot et al., 1963). Since then and until today, further evidence 
of this connection has been disclosed. The polysaccharide β-glucan is proposed to 
be responsible for the effect. β-Glucan is a viscous soluble fibre present in the 
endosperm cell walls and of which the highest amounts are found in oats and bar-
ley (Åman & Bryngelsson, 2009).  
This link between oat β-glucan and favourable cholesterol reductions opens up 
for the use of health claims on food products. In 2006, the European Food Safety 
Authority (EFSA) published a scientific opinion on health claims related to β-
glucans and maintenance of normal blood cholesterol concentrations. EFSA stated 
that the majority of human intervention trials found significant reductions in LDL-
cholesterol in response to a dose of at least 3 g β-glucan per day (EFSA, 2009), 
which is equal to 100 g rolled oats (Sonestedt, 2013). The U.S Food and Drug 
Administration (FDA) published a similar statement already in 1997 but included 
a requirement of 0.75 g β-glucan per portion in addition to the total daily dose of 3 
g (FDA, 1997). 
The cholesterol-lowering properties of β-glucan have been shown to vary based 
on the processing and use in products. Processing of cereals is a necessity for hu-
man consumption but some procedures have been reported to alter important char-
acteristics of β-glucan, which resulted in a lacking effect on cholesterol levels 
(Andersson et al., 2014). This information can be valuable in the manufacturing of 
new products and choice of processing, as well as in the use of health claims and 
for individuals who want to control their blood cholesterol concentrations.  
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1.1 Aim 
The purpose of this literature review was to compare the cholesterol-lowering 
effect of oat β-glucan in ready-to-eat cereals and bread. Differences in β-glucan 
content and characteristics in the products due to processing in relation to choles-
terol reduction were investigated.     
1.2 Method 
Information used in this literature review was collected from scientific articles, 
books and web data bases such as Scopus and Web of Science. Studies were de-
limitated to human trials with oat β-glucan incorporated to ready-to-eat cereals and 
bread or muffins, since these two products are easily accessible and common in 
the western diet. They can contain β-glucan of the same source but differ in sever-
al steps of manufacturing. Treatment diets with cookies or buns in addition to 
bread and muffins were included as well.  
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2 Background 
2.1 Properties of β-glucan 
The main underlying reason for the cholesterol-lowering effect of β-glucan is sug-
gested to be viscosity. The viscosity is primarily influenced by solubility and mo-
lecular weight distribution (Åman & Bryngelsson, 2009). Information about these 
factors is therefore interesting in studies where the link between β-glucan and cho-
lesterol is being examined. 
Solubility can be defined as the property of a solid polysaccharide, either pre-
sent in a solid food substance or not, to homogenously disperse in a liquid medi-
um. The solubility is affected by factors such as temperature, digestive enzymes 
and pH. Conditions similar to the gut environment is preferred when the solubility 
of β-glucan is analysed (Wang & Ellis, 2014).  
Dietary fibre and their components can be analysed by a variety of methods. β-
Glucans differ in molecular structure, size and solubility and the outcome of anal-
ysis is often difficult to compare, especially when different analytical methods are 
used. Difference in β-glucan molecular weight have also been shown to vary be-
tween oats of different growing conditions (Andersson et al., 2014). Some studies 
have as well reported variation in molecular weight between different varieties, 
while other have not observed any significant differences of this (Wood, 2001). 
β-Glucan consist of linear chains of about 30 % (1→3)- and 70 % (1→4)-linked 
β-D-glucopyranosyl units. The molecular weight of oat β-glucan is about 1-3 × 106 
g/mol. The (1→3)-linkages force the molecule to bend and prevent aggregation, 
which increase the molecule’s solubility in water. Longer series of (1→4)-linkages 
on the other hand probably lower solubility due to formation of junctions 
(Andersson et al., 2014). The extractability of β-glucan is a measure of the solubil-
ity (Wood, 2001). Oat β-glucan is 36-75 % extractable in hot water but might also 
be extracted by dilute acid or alkali. This can be more effective but increase deg-
radation (Andersson et al., 2014). Molecular weight, thickness of the cell and en-
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tanglement with other cell-wall components are examples of factors that also af-
fect extractability (Wood, 2001). 
2.2 Effects of processing 
EFSA’s opinion on the cholesterol-lowering effect of β-glucan is applicable on 
non-processed or minimally processed oat β-glucan (EFSA, 2009). However, the 
meaning of minimal processing is not defined, but the health claim generally re-
mains relevant as long as the viscosity is maintained (Åman & Bryngelsson, 
2009). Oat bran and oat bran concentrate is often used in products to achieve a 
high content of β-glucan. Oat bran is produced by sieving away starchy endosperm 
(Kulp, 2000). A high content of the subaleurone layer is thereby achieved and 
results in an oat bran that can contain as much as 10 % β-glucan. Oat bran concen-
trate is made by defatting and sieving. It can contain more than 20 % β-glucan. 
The solubility and molecular weight distribution of β-glucan remains rather un-
changed by quick and dry processes, e.g. production of oat bran. The β-glucan in 
extruded breakfast cereals, porridge and muffins are also relatively unaffected. 
However, wet and longer processes, such as bread making, increase the degrada-
tion of the quite sensitive linear chains of  β-glucan (Åman & Bryngelsson, 2009).  
A decrease in molecular weight (MW) and an increase in the relative amount of 
short-chained β-glucan have been observed during the making of both soft and 
crisp breads (Andersson et al., 2009). Fermentation of dough contributes to the 
breakdown but oven baking has no effect. Dough made of flour with high falling 
number retains MW of β-glucan to a greater extent. This suggests that endogenous 
enzymes play a role in the degradation (Andersson et al., 2008). β-Glucanases are 
present in wheat flour, which often is added in the making of oat bread and muf-
fins. These enzymes can increase the depolymerisation of β-glucan (Whitehead et 
al., 2014). Tosh et al. (2008) observed a reduction in MW of β-glucan in muffins 
treated with β-glucanase. Average MW decreased from 2200 kDa to 400 kDa. 
Simultaneously, solubility of β-glucan increased from 44 % to 57 %. When MW 
was further reduced to 120 kDa, solubility went down to 26 %.  
Extractability have been shown to increase during fermentation (Andersson et 
al., 2008). A higher content of rye β-glucan in crisp bread than soft bread, but with 
a lower extractability, was observed by Rakha et al. (2010). In the crisp bread, 
fermentation and extrusion increased extractability whilst oven baking did not 
have an effect. In a study by Beer et al. (1997), extractability and MW of oat bran 
β-glucan in muffins was investigated. The baking decreased molecular weight but 
increased extractability. Various muffins recipes resulted as well in different ex-
tractability of β-glucan. Frozen storage of muffins decreased extractability but 
MW was retained (Beer et al., 1997). Reduced solubility during storage in low 
8 
 
temperatures with low water availability has been detected in other studies as well. 
This might be due to reorganisation of β-glucan chains and an increased structural 
arrangement (Wang & Ellis, 2014).  
Commercial extruded ready-to-eat cereals retain a high MW of β-glucan and 
have possibly an increased bioactivity. This is because of disruption of the cell 
wall and dispersion of β-glucan during the process (Tosh et al., 2010). Tosh et al. 
(2010) observed maintained high MW and increased solubility, from 39 % to 67 
%, in an extruded cereal. A high viscosity was thereby achieved and a greater cho-
lesterol-lowering effect than of the original bran product was expected.  
2.3 Cholesterol and lipoproteins  
Cholesterol is a fat soluble alcohol, a sterol. It consists of a 17 carbon sterol struc-
ture with a hydrocarbon chain, two methyl groups and is sometimes esterified with 
a fatty acid. The cholesterol is used for production of steroid hormones, mem-
branes, vitamin D and bile acids. Cholesterol metabolism is carefully controlled in 
healthy individuals. Large amounts of cholesterol in the diet lower endogenous 
production and small amounts increase it (Becker, 2013).  
Lipids are transported in the blood as lipoproteins. These consist of an am-
phiphilic outer layer of apolipoproteins and phospholipids, and a water insoluble 
centre of triglycerides and esters of cholesterol. Two of the main groups of lipo-
proteins are low density lipoprotein (LDL) and high density lipoprotein (HDL). 
The higher the density of the lipoprotein, the more protein and less triglyceride 
content. LDL has about 45 % content of cholesterol and provides cholesterol to 
cells when the endogenously synthesized amount is not enough. Residual choles-
terol is transported in the form of HDL to the liver, which is the only organ that 
can discard cholesterol. HDL consist of about 22 % cholesterol and apart from 
transport to the liver, it carries proteins and excess breakdown material (Becker, 
2013). 
LDL-cholesterol increase accumulation of fat-laden macrophages in the wall of 
veins and is therefore commonly called “bad” cholesterol. HDL-cholesterol, as 
well as a small ratio of total cholesterol and HDL-cholesterol, have on the other 
hand been shown to decrease the risk of cardiovascular disease and is called the 
“good” cholesterol (Becker, 2013). Individuals with cardiovascular disease or 
other risk factors are recommended a total cholesterol level of 5.0 mmol/l or low-
er. The LDL-cholesterol level should be less than 3.0 mmol/l and HDL-cholesterol 
more than 1.0 mmol/l (Touminen, 2015). 
LDL-cholesterol and HDL-cholesterol levels are affected by several factors. A 
diet with a lot of saturated fat increase LDL-cholesterol in plasma. Premenopausal 
women generally have higher HDL-cholesterol levels than men (Becker, 2013). 
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Smoking and large amounts of alcohol have a negative effect while physical activ-
ity has a positive impact. Type 2-diabetics often have high levels of triglycerides 
and low levels of HDL-cholesterol (Touminen, 2015).  
2.4 Cholesterol lowering mechanism 
The mechanism by which β-glucan lowers serum cholesterol is not completely 
established. In a review by Gunness and Gidley (2010) three possible modes of 
actions are summarised. It is suggested that soluble fibre bind to bile acids and 
increase their excretion by inhibiting re-absorption. This results in an increased 
hepatic bile acid production from cholesterol either endogenously synthesized or 
taken from the circulation (Ellegård & Andersson, 2007; Lia et al., 1997). Micro-
biotic fermentation of β-glucan in the colon might also have an impact. The fer-
mentation results in short-chained fatty acids (SCFAs). One of probably many 
effects of SCFAs, mainly propionate, is inhibition of HMG-CoA reductase. This is 
the rate-controlling enzyme of cholesterol synthesis (Levrat et al., 1994). How-
ever, studies in this area have shown varying results (Gunness & Gidley, 2010). 
Another possible mode of action is lowered glycaemic response by the delay of 
gastric emptying, influence on nutrient absorption in the small intestine and re-
duced insulin levels (Sonestedt, 2013). Insulin can contribute to lowered choles-
terol by also inhibiting HMG-CoA reductase. Since insulin levels are affected by 
several factors, it is difficult to differentiate its effects with the influence of β-
glucan viscosity and above mentioned mechanisms (Gunness & Gidley, 2010).  
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3 Studies 
 
3.1 Cereals 
Six studies on the cholesterol lowering effect of oat β-glucan incorporated to 
ready-to-eat cereals were selected for comparison and are presented in Table 1. 
Characteristics of the study, product with β-glucan and any significant change in 
blood lipid concentrations are featured in the table. 
In a study by Lovegrove et al. (2007), 31 women and 31 men consumed 3.0 g of 
β-glucan from oat bran concentrate (OBC) per day in oat bran cereal for 8-weeks. 
The trial was finished by a 4-week follow up period. Mean age of study objects 
was 56.6 years and mean baseline body mass index (BMI) 26.0. In the beginning 
of the trial, TC and LDL-C levels in the β-glucan group were 6.5 and 4.3 mmol/l, 
respectively, and 6.4 and 4.3 for the control group. The control group consumed a 
wheat cereal product. No significant change in fasting plasma cholesterol or LDL-
C between the two groups was observed. HDL-C levels were lowered.  
RTE oat flakes with 1.45 g of β-glucan per day were consumed in a study by 
Charlton et al. (2012). This was one of three diet arms that lasted for 6 weeks and 
26 subjects completed the β-glucan treatment. The control group consisted of 31 
subjects and received cornflakes. Mean age was 51 years and mean BMI 27.3. At 
baseline, TC and LDL-C levels in the β-glucan group were 6.12 and 3.84 mmol/l, 
respectively, and 6.03 and 3.86 for the control group. The peak molecular weight 
of the β-glucan was 760 kDa and the solubility (of total β-glucan) was 90.62 %. 
Compared to control, the β-glucan group lowered TC by 3.8% and LDL-C by 8.5 
%.  
Wolever et al. (2010) studied the effect of oat β-glucan of different molecular 
weights incorporated to extruded RTE cereal. During 4 weeks, subjects were as-
signed to one of five treatments; 3 g β-glucan/day of high-MW (2210 kDa, n=86, 
y=52), 4 g β-glucan/day of medium-MW (850 kDa, n=67, y=52), 3 g β-glucan/day 
of medium-MW (530 kDa, n=64, y=52), 4 g β-glucan/day of low-MW (210 kDa, 
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n=63, y=53) or control (wheat cereal, n=87, y=52). Products of lower MW was 
made by increased temperature and shear and decreased moisture content during 
extrusion. Mean baseline BMI was 27.4. Initially, subjects had TC levels between 
5.0 and 8.0 mmol/l, and LDL-C levels between 3.0 and 5.0 mmol/l. After treat-
ment and compared to the control group, all β-glucan cereals, except 4 g low-MW, 
significantly lowered LDL-C. The 3 g high-MW reduced TC as well. 
In a study by Johnston et al. (1998), 40 women and 22 men consumed 2.9 g oat 
soluble fibre per day through whole grain oat RTE cereal, Cheerios, for 6 weeks. 
A 6-week pre-treatment period was completed before the intervention. The control 
group consisted of 62 people that consumed cornflakes. Mean age of subjects was 
57 years. Subjects taking medications such as androgens and lipid lowering drugs 
were not included in the study. Subjects taking e.g. oestrogen and beta blockers 
that possibly affect lipid levels were accepted if doses were stable. In the begin-
ning of the trial, TC and LDL-C levels in the β-glucan group were 6.19 and 4.10 
mmol/l, respectively, and 6.14 and 4.15 for the control group. Compared to the 
control group, TC was lowered by 3.8 % and LDL-C by 4.2 % in the β-glucan 
group.  
In a 6-week study by Karmally et al. (2005), 73 Hispanic Americans consumed 
3.0 g oat soluble fibre per day through RTE oat cereal, Cheerios. The control 
group consisted of 79 subjects that consumed corn cereal. Both groups completed 
a 5-week diet run in period before the intervention. Mean age was 49 years and 
mean baseline BMI 29.3. Initially, TC and LDL-C levels in the β-glucan group 
were 5.41 and 3.67 mmol/l, respectively, and 5.16 and 3.45 for the control group. 
The β-glucan group lowered TC by 4.5 % and LDL-C by 5.3 % compared to base-
line. No significant changes were observed in the control group.  
In a 12-week study by Maki et al. (2010), 58 women and 19 men consumed a 
whole-grain RTE cereal, providing 3.0 g β-glucan per day, as part of a dietary 
program for weight loss. Diet recommendations were set to aim for an energy 
deficit of about 500 kcal/day, for a weight loss of around 0.5 kg/week. The control 
group consisted of 67 subjects and received a low fibre diet with e.g. corn cereal 
and white toast. The mean age was 49 years and mean BMI 32.0. At baseline, TC 
and LDL-C levels in the β-glucan group were 6.0 and 4.0 mmol/l, respectively, 
and 5.9 and 4.0 for the control group. No difference in weight loss was observed 
between the groups, but the waist circumference in the β-glucan group decreased 
more. Compared to baseline, TC was lowered by 5.4 % and LDL-C by 8.7 % in 
the β-glucan group.  
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Table 1. Characteristics of studies with cereal products.  
Study Product (source  
of β-glucan) 
Dose of β-glucan 
(g/d) 
MW of β-glucan 
(kDa) 
Study design Subjects 1 Change in blood 
lipids (%) 
Lovegrove et al. 
(2007) 
Oat bran cereal 
(OBC3) 
3.0  8-week double-
blind, controlled, 
randomized parallel 
trial 
n=62 
y=56.6 
HDL -7.6 
Charlton et al. 
(2012) 
 
Oats low: Extruded 
RTE4 oat flakes 
1.45 760 
 
6-week parallel, 
randomized, con-
trolled, single-blind 
trial 
n=57 
y=51 
 
TC -7.2 
LDL-C -8.5  
Wolever et al. 
(2010) 
Extruded RTE4 
cereal5 
(oat bran) 
3H: 3.0 
4M: 4.0 
3M: 3.0 
4L: 4.0 
3H: 2210 
4M: 850 
3M: 530 
4L: 210 
4-week randomized, 
controlled, double-
blind, parallel trial 
3H: n=86, y=52 
4M: n=67, y=52 
3M: n=64, y=52 
4L: n=63, y=53 
 W6: n=87, y=52 
3H: LDL-C -5.5 
       TC -3.9 
4M: LDL-C -6.5 
3M: LDL-C -4.7 
 4L: LDL-C -2.37 
Johnston et al. 
(1998) 
RTE4 oat cereal 
(whole grain oat 
flour) 
2.92  6-week parallel, 
randomized, con-
trolled trial 
n=124 
y=57 
TC -3.8 
LDL-C -4.2 
Karmally et al. 
(2005) 
RTE4 oat cereal  
(whole grain oat 
flour) 
3.02  6-week, random-
ized, controlled trial 
n=152 
y=49.0 
 
TC -4.5 
LDL-C -5.3 
Maki et al. (2010) RTE4 oat cereal  
(whole grain oat 
flour) 
3.0  12-week  random-
ized, parallel-arm, 
controlled trial 
n=144 
y=48.9 
TC -5.4 
LDL-C -8.7 
 
1 n: number of subjects receiving treatment or control, y: mean age, 2 soluble fibre (g/d), 3 OBC: oat bran concentrate, 4 RTE: ready-to-eat, 5 Four cereal products made during 
different extrusion conditions giving high (H), medium (M) or low (L) molecular weight, 6 Control group consuming wheat cereal, 7 not statistically significant 
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 3.2 Bread 
Five studies on the cholesterol lowering effect of oat β-glucan incorporated to 
bread, muffins and cookies were selected for comparison and are presented in 
Table 2. Characteristics of the study, the product with β-glucan and any significant 
change in blood lipid concentrations are featured in the table.  
In a 4-week study by Robitaille et al. (2005), 18 premenopausal women con-
sumed oat bran muffins giving a total 2.31 g β-glucan each day. Muffins were 
prepared by the study objects at home. Eggs, oil and water was supposed to be 
added to the mix of pre-packaged dry ingredients. The control group consisted of 
16 premenopausal women receiving no supplement. A 2-week run-in period was 
completed before the treatment. Mean age was 38.3 years and mean baseline BMI 
28.8. Initially, TC and LDL-C levels in the β-glucan group were 4.79 and 2.76 
mmol/l, respectively, and 4.80 and 2.75 for the control group. Compared to the 
control group, HDL-C levels increased by 11.2 %. No significant change was ob-
served for TC and LDL-C levels.  
The effect of β-glucan incorporated in bread and cookies was investigated in 
study 1 by Kerckhoffs et al. (2003). During the 4-weeks of treatment, which was 
done after a 3-week run-in period, 25 subjects consumed the β-glucan products 
and 23 subjects got control bread and cookies with wheat fibre. Mean age was 
51.5 years and mean baseline BMI 25.6. After baking, cookies and bread were 
frozen. Bread that had been frozen had a molecular weight distribution of 15 % > 
1000 kDa, 30 % 250-1000 kDa and 55 % <250 kDa. Cookies that had been frozen 
had a molecular weight distribution of 40 % > 1000 kDa, 45 % 250-1000 kDa and 
15 % <250 kDa. At baseline, TC and LDL-C levels in the β-glucan group were 
5.98 and 3.96 mmol/l, respectively, and 6.00 and 4.09 for the control group. Out of 
the average consumption of 5.9 g β-glucan per day, 5.1 g came from bread and 0.8 
g from cookies. After treatment, no significant difference was observed between 
the two groups. 
The impact of oat soluble fibre in bread, buns and muffins was studied by Pick 
et al. (1996). The 24-week crossover study consisted of two 12-week periods, 
without any additional time in-between. Study subjects were 8 men with a mean 
age of 45 years and mean baseline BMI of 27.6, type 2-diabetes and initial TC 
levels were less than 7 mmol/l. Four subjects consumed the oat soluble fibre prod-
ucts for the first period, while the other four consumed the control white bread. At 
the second period diets switched. TC and LDL-C levels resulted in a 14 % and 23 
% decrease, respectively, after the oat soluble fibre period in comparison to the 
white bread period.   
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In a study by Liatis et al. (2010), 12 men and 11 women with type 2-diabetes 
consumed bread enriched with 3.0 g β-glucan from OBC per day for 3 weeks. The 
control group consisted of 18 subjects who received a similar wheat bread. Mean 
age was 63 and mean baseline BMI 29.6. In the beginning of the trial, TC and 
LDL-C levels in the β-glucan group were 6.25 and 4.18 mmol/l, respectively, and 
5.88 and 4.06 for the control group. After treatment and compared to the control 
group, TC and LDL-C levels decreased by 5 and 10 %, respectively, in the β-
glucan group.  
Kestin et al. (2012) compared the effect of oat bran to rice bran and wheat bran 
in a cross-over trial. Oat soluble fibre, 5.8 g each day, was provided through bread 
and muffins. Study subjects were 24 men with a mean age of 46 years and a mean 
baseline BMI of 25.4. In the beginning of the trial, mean TC and LDL-C levels 
were 6.34 and 4.55 mmol/l, respectively. After an initial 3-week low-fibre diet, 
subjects were assigned to one of the three fibre diets for 4 weeks each in a crosso-
ver design. The oat diet significantly lowered TC by 5.6 % compared to the wheat 
diet and by 3.8 % compared to the rice diet. LDL-C was lowered by 6.6 % com-
pared to the wheat diet and by 5.5 % compared to the rice diet.  
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Table 2. Characteristics of studies with bread, muffins and cookies.  
Study Product (source  
of β-glucan) 
Dose of β-glucan 
(g/d) 
MW of β-glucan 
(kDa) 
Study design Subjects 1 Change in blood 
lipids (%) 
Robitaille et al. 
(2005) 
Muffins 
(oat bran) 
2.31  4 week randomized, 
controlled trial 
n=34 
y=38.3 
Only women 
HDL-C +11.2 
Kerckhoffs et al. 
(2003) 
 
Study 1: Bread, 
cookies 
(oat bran, OBC3) 
5.9 Frozen bread:  
15 % >1000 
30 % 250-1000 
55 %<250 
Frozen cookie: 
40 % >1000 
45 % 250-1000 
15 %<250 
4-week parallel 
randomized, con-
trolled trial 
n=48 
y=51.5 
No significant 
change 
Pick et al. (1996) Bread, buns, muf-
fins (OBC3) 
9.02  12-week 
cross-over 
n=8 
y=45.5 
Type 2-diabetics 
Only men 
TC -14 
LDL-C -23 
Liatis et al. (2010) Bread (OBC3) 3.0  3-week randomized, 
controlled, double-
blind 
n=41 
y=63 
Type 2-diabetics 
TC -5 
LDL-C -10 
Kestin et al. (2012) Bread, muffins 
(oat bran) 
5.82  4-week double 
blind, crossover 
trial 
n=24 
y=46.0 
Only men 
TC -5.6  
LDL-C -6.6 
 
1 n: number of subjects receiving treatment or control, y: mean age, 2 soluble fibre, 3 OBC: oat bran concentrate 
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4 Discussion 
Eight out of the selected eleven studies reported a significant decrease in TC and 
or LDL-C. In terms of dose of β-glucan and study subjects, the studies with RTE 
cereals had more similarities and achieved more consistent results compared to the 
studies with bread. Possible reasons for the observed differences are discussed in 
the following section.  
4.1 No significant effect of treatment 
Lovegrove et al. (2007), Kerckhoffs et al. (2003) and Robitaille et al. (2005) did 
not achieve any significant change in neither TC nor LDL-C after treatment. β-
Glucan in the three studies was consumed through different products (oat bran 
cereal, bread and cookies, and muffins) and of different doses (3.0 g/d, 5.9 g/d and 
2.31 g/d). Study design was similar in all three cases. Several factors can contrib-
ute to the absent reduction in cholesterol. The β-glucan was possibly not soluble 
enough, or did not disperse in the intestine. The dose and molecular weight were 
perhaps too low, or negatively affected by processing and storage (Wolever et al., 
2010). It has also been suggested that a lack of effect is connected to the frequency 
of ingestion of beta-glucan. Repeated intake of beta-glucan during the day possi-
bly increase hepatic bile acid production in greater occurrence than a single larger 
intake (Othman et al., 2011).  
Detailed information about the products and β-glucan used in these three studies 
are lacking. Only Kerckhoffs et al. (2003) reported molecular weight of β-glucan. 
In bread, 55 % was less than 250 kDa, which contributed with the highest total 
consumed amount, and 45 % between 250-1000 kDa in cookies. In a separate part 
of the study (study 2), the effects of β-glucan incorporated to a drink was exam-
ined and unlike study 1, a decrease in LDL-C was observed. The source of β-
glucan was the same in both studies, and the molecular weight distribution was 
similar. Therefore, these two factors are suggested to not be the reason for lack of 
effect. Instead is the baking of bread believed to be the cause, since studies on β-
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glucan in bread have observed varying results of cholesterol reduction (Kerckhoffs 
et al., 2003). No information about the ingredients in the bread is provided in the 
report but if yeast and wheat flour was mixed into the dough, the outcome of the 
study was probably affected. During the time of fermentation, MW decreases and 
solubility increases, due to the activity of β-glucanases from flour (Andersson et 
al., 2008). Tosh et al. (2008) found a drop in solubility in response to MW lower 
than 400 kDa. Since the β-glucan MW distribution in bread in Kerckhoffs et al. 
(2003) by 55 % was constituted of ≤ 250 kDa, it is plausible that solubility was 
also decreased. The cookies and bread had been frozen before consumption, which 
as well have been reported to reduce solubility of β-glucan (Wang & Ellis, 2014). 
Possibly, the aggregative effect is both lowered MW and solubility to the extent of 
loss of cholesterol reducing properties of β-glucan.  
In the study by Robitaille et al. (2005), muffins were prepared by the study ob-
jects at home according to instructions. The control group did not receive any con-
trol product, while control groups in the other studies consumed a corresponding 
wheat product. These two factors decrease the level of control over the subjects’ 
actions and have possibly contributed to the outcome. Subjects were only women 
and had considerable lower baseline TC and LDL-C values compared to the previ-
ous two studies, which might have had an effect. However, EFSA’s scientific 
opinion concerns adults with normal as well as mildly elevated blood cholesterol 
(EFSA, 2009).  
A change could also have been undetected due to major variability in TC and 
LDL-C concentrations after treatment (Robitaille et al., 2005). Robitaille et al. 
(2005) reported an increase in HDL-C, while Lovegrove et al. (2007) measured a 
decrease. Robitaille et al. (2005) suggests that the observed increase in their study 
was enhanced due to the low-dietary fat run-in period, which decreased HDL-C 
concentrations before the following oat bran-diet. Lovegrove et al. (2007) point 
out that the observed undesired decrease in HDL-C is statistically significant, alt-
hough this reduction is quantitatively smaller than that of TC and LDL-C. It is 
further discussed that the lack of response could possibly be explained by a too 
low dosage of β-glucan or too few subjects for statistical significance. However, 
the viscosity, which was slightly more than six times higher than in the control, is 
not believed to be the cause.  
4.2 Molecular weight and effects of processing 
Beside Kerckhoffs et al. (2003), two of the selected studies, Charlton et al. (2012) 
and Wolever et al. (2010), contained information about MW of the β-glucan. The 
extruded RTE oat flakes in the study by Charlton et al. (2012) provided 1.45 g β-
glucan/day, with a 90.6 % solubility and MW of 760 kDa. This was in terms of 
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MW most similar to extruded RTE cereal 4M (850 kDa), and in regard to solubili-
ty most similar to 3M (93.3 %), in the study by Wolever et al. (2010). Compared 
to these two and despite the low dose of 1.45 g β-glucan/day, a greater reduction 
in LDL-C was observed by Charlton et al. (2012). Both studies discuss that Mp × 
C (molecular weight of β-glucan in solution and daily dose of soluble β-glucan) is 
a favourable measure of β-glucan bioactivity and it is suggested that as the Mp × C 
increases, so does viscosity (Wolever et al., 2010). Both 3M and 4M have a higher 
Mp × C, 1500 and 2700, respectively, than the oat flakes in Charlton et al. (2012) 
which has a value of 1000. Thus, more factors presumably affected the outcome 
and contributed to the considerable decrease in LDL-C. The two studies had simi-
lar design, but Charlton et al. (2012) had a two-week longer treatment period and a 
background diet with a low fat intake.  
Regarding the effect of processing in both cereals and bread when examining 
earlier published literature, extruded RTE cereals with β-glucan often seem pro-
posed to be more effective in lowering cholesterol, or maintaining normal choles-
terol concentrations, in comparison with bread (Andersson et al., 2014). The re-
tained MW and even dispersion of β-glucan in that type of cereal product (Tosh et 
al., 2010), without any need for fermentation and mixing with wheat flour for 
longer periods of time as in bread, is possibly the key to success in this case. How-
ever, comparison of these factors and effects in bread and cereals are difficult 
since only eleven studies were selected for comparison in this literature review. 
The majority lack information about viscosity and for those that do provide it, is it 
important to remember that differences in MW and solubility can vary between 
different methods of analysis and conditions during measurement (Andersson et 
al., 2014).  
4.3 Significant effect of treatment 
The greatest reduction in TC and LDL-C of the selected studies was reported by 
Pick et al. (1996) where 9.0 g/d of soluble fibre, with β-glucan originating from 
OBC provided through bread, buns and muffins, was the highest dose used in all 
studies. Study subjects were men with type 2-diabetes. Two studies were similar to 
this study, regarding the diabetic subjects in Liatis et al. (2010) and in terms of 
being a cross-over with male subjects and a high soluble fibre content in Kestin et 
al. (2012). Although significant changes in cholesterol levels in these two studies, 
the decrease was two or three times larger in Pick et al. (1996). The high dose of 
soluble fibre and long treatment period are presumably the underlying causes to 
this. However, conflicting conclusions about the importance of these factors have 
been reported. A 6-week study investigating the blood cholesterol-lowering effect 
of oatmeal and oat bran detected a dose-dependent decrease (Davidson et al., 
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1991). On the contrary, a meta-analysis of 28 randomized clinical trials found no 
significance of neither duration nor dose, when over 2 weeks and 3 g β-
glucan/day. This meta-analysis included both above mentioned studies with dia-
betics, as well as one other, and concluded that the cholesterol-lowering effect is 
greater in diabetic subjects. This effect is purposed to be linked to an insulin-
dependent mechanism (Whitehead et al., 2014).  
Maki et al. (2010), Karmally et al. (2005) and Johnston et al. (1998) all used the 
commercially available RTE oat cereal Cheerios as intervention product. A very 
similar change in blood cholesterol concentration was observed in the three stud-
ies. Maki et al. (2010) reported the greatest decrease, which possibly is explained 
by the intentional weight loss and the twice as long treatment period compared to 
the other two studies. Weight loss have earlier been associated with reduced blood 
lipids and lipoproteins in overweight individuals (Dattilo & Kris-Etherton, 1992). 
All studies included in this review, except for Johnston et al. (1998), reported the 
mean BMI of subjects to be over 25, which is considered to be the limit of defin-
ing as overweight (Risérus et al., 2013). Amongst the six studies on β-glucan in-
corporated in RTE cereals, body weight was maintained stable during the treat-
ment period in order to not affect cholesterol concentrations other than by the as-
signed intervention product. In contrast to this, Maki et al. (2010) aimed for 
weight loss. The treatment and control group in this study achieved similar weight 
loss. However, a greater decrease in waist circumference was observed in the 
treatment group, which is linked to lowered risk for metabolic complications 
(Wirfält & Andersson, 2013). This positive outcome is possibly in response to the 
higher dose of β-glucan, which was the only factor differing between the two 
groups. 
4.4 Health claims 
Increasing total- and LDL-cholesterol levels are risk factors for cardiovascular 
disease. An approved health claim for a food product can, apart from being fa-
vourable for the manufacturer, increase the costumers’ awareness. Since EFSA’s 
scientific opinion do not specify the meaning of non-processed or minimally pro-
cessed oat β-glucan, studies with seemingly similar products report quite varying 
results. As shown in Table 1 and Table 2, the required dose of 3.0 g β-glucan per 
day do not per se imply a favourable outcome. Increased knowledge of the choles-
terol lowering mechanism and effects of processing oat β-glucan could possibly 
adapt the use of the health claim and result in a more effective control over blood 
cholesterol concentrations. However, it is probably possible for the public to 
achieve that positive effect at todays 3.0 g limit anyways, considering the wide 
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range of products that can be enriched with β-glucan in the form of either rolled 
oats, oat bran or oat bran concentrate.  
4.5 Conclusion 
Along the lines with earlier observations, consumption of RTE cereals with oat β-
glucan seem to result in a greater cholesterol reduction than of bread, due to the 
more beneficial effects of processing on molecular weight and solubility of the β-
glucan. To increase the certainty of this conclusion, more studies that include in-
formation about the properties of the β-glucan would be desirable. 
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